Dr. Yu Zhao

Co-founder of PHIL RIVERS TECHNOLOGY; Research Professor at the Western Institute of Computing Technology; Deputy Director of the Turing-Darwin Laboratory; Leading Talent of the Beijing High-end Leading Talent Gathering and Cultivation Project; Vice Chairman of the AI and Big Data Division, China Bio-Medical Industry Chain Innovation and Transformation Alliance; Joint Expert of the Research and Industrial Transformation of Cell and Gene Therapy in Medical Institutions Project; Convener of the Computational Medicine Salon.

An initiator and advocate of computational medicine, long engaged in AI-life sciences research and industrial practice, leading multiple national and Beijing municipal key projects. Computational medicine focuses on "AI4S + Disease", decoding laws of life and disease mechanisms to pioneer a new paradigm for life and health innovation and translation.

Built on the WHIRLPO computational medicine platform, with capabilities to understand and simulate life systems, now serving key drug R&D stages: target discovery, indication matching, benefiting population identification, and efficacy prediction.

With Peking University Cancer Hospital, completed the world's first and only two prospective virtual clinical trials; partners with multiple national medical centers on mechanism and target research in oncology, immunology, psychiatry, metabolic and rare diseases.